Vanguard Portfolio Management’s SpyGlass Pharma SGP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGP
Vanguard Portfolio Management's SGP Position: Q3 2026 in Review
Vanguard Portfolio Management reduced its SpyGlass Pharma (SGP) stake by 14% in Q3 2026, selling an estimated $266K and leaving 65,015 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2758.
Vanguard Portfolio Management first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. 70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.
- Vanguard Portfolio Management held 65,015 shares of SpyGlass Pharma worth $1.69M as of Q3 2026.
- Vanguard Portfolio Management sold 10,797 SpyGlass Pharma shares in Q3 2026, an estimated $266K.
- SpyGlass Pharma made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #2758 holding.
- Vanguard Portfolio Management first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
- 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.